Aarti Pharmalabs LimitedAarti Pharmalabs LimitedAarti Pharmalabs Limited

Aarti Pharmalabs Limited

No trades
See on Supercharts
Market capitalization
‪75.83 B‬INR
29.40INR
‪2.72 B‬INR
‪20.88 B‬INR
‪52.14 M‬
Beta (1Y)
1.01
Employees (FY)
‪3 K‬
Change (1Y)
−178 −5.59%
Revenue / Employee (1Y)
‪6.95 M‬INR
Net income / Employee (1Y)
‪906.51 K‬INR

About Aarti Pharmalabs Limited


Headquarters
Mumbai
Founded
2019
ISIN
INE0LRU01027
FIGI
BBG01B1YBKP4
Aarti Pharmalabs Ltd. engages in the manufacture and sale of pharmaceutical and nutraceutical products. It offers active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xathine derivatives. The company was founded on November 22, 2019 and is headquartered in Mumbai, India.

Check out other big names from the same industry as AARTIPHARM.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SMIN
iShares MSCI India Small Cap ETF
Weight
0.11%
Market value
‪974.78 K‬
USD
EPI
WisdomTree India Earnings Fund
Weight
0.03%
Market value
‪713.65 K‬
USD
EWX
SPDR S&P Emerging Markets Small Cap ETF
Weight
0.04%
Market value
‪311.97 K‬
USD
DFEV
Dimensional Emerging Markets Value ETF
Weight
0.02%
Market value
‪242.03 K‬
USD
AVEE
Avantis Emerging Markets Small Cap Equity ETF
Weight
0.05%
Market value
‪28.92 K‬
USD
MOHEALTH
Motilal Oswal S&P BSE Healthcare ETF
Weight
0.32%
Market value
‪11.76 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of AARTIPHARM is 856.25 INR — it has increased by 2.33% in the past 24 hours. Watch Aarti Pharmalabs Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Aarti Pharmalabs Limited stocks are traded under the ticker AARTIPHARM.
AARTIPHARM stock has risen by 2.20% compared to the previous week, the month change is a −8.81% fall, over the last year Aarti Pharmalabs Limited has showed a 34.40% increase.
AARTIPHARM reached its all-time high on Jul 16, 2025 with the price of 971.00 INR, and its all-time low was 234.80 INR and was reached on Feb 3, 2023. View more price dynamics on AARTIPHARM chart.
See other stocks reaching their highest and lowest prices.
AARTIPHARM stock is 3.47% volatile and has beta coefficient of 1.01. Track Aarti Pharmalabs Limited stock price on the chart and check out the list of the most volatile stocks — is Aarti Pharmalabs Limited there?
Today Aarti Pharmalabs Limited has the market capitalization of ‪75.83 B‬, it has increased by 0.13% over the last week.
Yes, you can track Aarti Pharmalabs Limited financials in yearly and quarterly reports right on TradingView.
AARTIPHARM net income for the last quarter is ‪495.01 M‬ INR, while the quarter before that showed ‪883.41 M‬ INR of net income which accounts for −43.97% change. Track more Aarti Pharmalabs Limited financial stats to get the full picture.
Aarti Pharmalabs Limited dividend yield was 0.67% in 2024, and payout ratio reached 16.64%. The year before the numbers were 0.69% and 12.53% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 16, 2025, the company has ‪3 K‬ employees. See our rating of the largest employees — is Aarti Pharmalabs Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aarti Pharmalabs Limited EBITDA is ‪4.63 B‬ INR, and current EBITDA margin is 21.17%. See more stats in Aarti Pharmalabs Limited financial statements.
Like other stocks, AARTIPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aarti Pharmalabs Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aarti Pharmalabs Limited technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aarti Pharmalabs Limited stock shows the buy signal. See more of Aarti Pharmalabs Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.